4-(4-甲基-1-哌嗪基)-7-(三氟甲基)-吡咯并[1,2-a]喹喔啉二马来酸盐 | 109028-10-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 4-(4-甲基-1-哌嗪基)-7-(三氟甲基)-吡咯并[1,2-a]喹喔啉二马来酸盐
• 中文别名: 7-三氟甲基-4-(4-甲基-1-哌嗪基)吡咯并[1,2-a]-喹喔啉双马来酸酯
• 英文名称: CGS-12066A maleate
• 英文别名: (Z)-but-2-enedioic acid;4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline
• CAS: 109028-10-6
• 化学式: C21H21F3N4O4
• 分子量: 450.4
• InChiKey: ZBPAHEUAJMCLRD-BTJKTKAUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.97
• 重原子数：
  32
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  98.4
• 氢给体数：
  2
• 氢受体数：
  10

文献信息

• [EN] THE USE OF 5-HT1B/1D AGONISTS TO TREAT OCULAR PAIN<br/>[FR] UTILISATION D'AGONISTES DE 5-HT1B/1D DANS LE TRAITEMENT DE DOULEURS OCULAIRES
  申请人：ALCON LABORATORIES, INC.

  公开号：WO1997044062A1

  公开（公告）日：1997-11-27

  (EN) Compositions and methods for treating ocular pain are disclosed. In particular, the invention discloses compositions and methods of using 5-HT1B/1D agonists for the prevention or alleviation of ocular pain.(FR) Cette invention concerne des compositions et des procédés de traitement de douleurs oculaires. Cette invention concerne plus particulièrement des compositions ainsi que des procédés d'utilisation d'agonistes de 5-HT1B/1D dans la prévention ou le soulagement de douleurs oculaires.
• [EN] USE OF 5-HT1B/1D AGONISTS TO TREAT OTIC PAIN<br/>[FR] UTILISATION D'AGONISTES DE 5-HT1B/1D POUR LE TRAITEMENT DES DOULEURS OCULAIRES
  申请人：ALCON LAB INC

  公开号：WO2001015677A2

  公开（公告）日：2001-03-08

  Compositions and methods for treating otic pain are disclosed. In particular, the invention discloses compositions and methods of using 5-HT1B/1D agonists for the prevention or alleviation of otic pain.
• [EN] COMPOUNDS USED FOR TREATING CANCER AND THE USE THEREOF<br/>[FR] COMPOSÉS UTILISÉS POUR TRAITER LE CANCER ET UTILISATION ASSOCIÉE
  申请人：LAI HUNG-CHENG

  公开号：WO2012079232A1

  公开（公告）日：2012-06-21

  The invention discloses compounds used for treating cancer and the use thereof. The compounds comprise ammonium pyrrolidinedithiocarbamate, (E)3-((4- tertbutytphenyl) sulfonyl)-2-acrylonitrile, (2'Z,3'Z)-6-bromoindirubin-3'-oxime, γ-4-dihydroxyl-2-(6-hydroxyl-1-heptenyl)-4-cyclopentanecrotonic acidλ.- lactone, butalamol, calcimycin, bis(4-chlorophenyl)methyl)-3-(2-(2,4-dichlorophenyl)-2-((2,4- dichlorophenoxy)ethyl-1H-imidazolium salts, chelerythrine chloride, 4,5,6,7- tetrabromo-benzimidazole, N2-(cis-cyclohexaneamine)-N6-(3-chlorophenyl)-9-ethyl- 9H-purin-2,6-diamine hydrochloride, 7-trifluoromethyl-4-(4-methyl-1-piperazinyl)- pyrrolo[1,2-a]quinoxaline maleate, dequalinium dichloride, dihydroouabain, diphenyleneiodonium chloride, emetine dihydrochloride hydrate, N-[4-Methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4- triazol-3-yl)[1,1'-biphenyl]-4-carboxamide hydrochloride, 2,2-dimethyl- 3,4-dihydro -2H-benzo[1,2B]chromene-5,6-dione, niclosamide, nifedipine, 6-nitroso-1,2- benzopyrone, palmitoyl-DL-carnitine chloride, parthenolide, 4- (4-fluorophenyl) -2-(4-nitrophenyl)-5-(4-pyridine)-1H-imidazol, 1,10-phenanthroline monohydrate, 4-phenyl-3-furoxancarbonitrile, prazosin hydrochloride, protoporphyrin disodium, quinacrine dihydrochloride, ouabaim, retinoic acid p-hydroxyanilide, rottlerin, sanguinarine chloride, tetraethylthium, 3-[1-(3H-imidazol-4-yl)-meth- (Z)-ylidene]-5-methoxy- 1,3-dihydro-2-indolinone. The invention also discloses the use of the compounds for preparing medicament of treating cancer and inhibiting the growth of cancer cell and cancer stem cell.